Drug Compare

Advertisement
 1  2  3  
  • Basic Info
Licensed from
Generic: certolizumab
View All Brands
An immunosuppressive monoclonal antibody - It is used to treat Crohn's disease or rheumatoid arthritis
               



To get info about second drug, type a name above.


What if I miss a dose?

It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment. If you give yourself the medicine and you miss a dose, take it as soon as you can. If it is almost time for your next dose, take only that dose. Do not take double or extra doses.

What may interact with this medicine?

Do not take this medicine with any of the following medications:

This medicine may also interact with the following medications:

  • vaccines

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non- prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medicine?

Visit your doctor or health care professional for regular checks on your progress. Tell your doctor or healthcare professional if your symptoms do not start to get better or if they get worse. Your condition will be monitored carefully while you are receiving this medicine.

You will be tested for tuberculosis (TB) before you start this medicine. If your doctor prescribes any medicine for TB, you should start taking the TB medicine before starting this medicine. Make sure to finish the full course of TB medicine.

Call your doctor or health care professional for advice if you get a fever, chills, sore throat, or other symptoms of an infection. Do not treat yourself. This medicine may decrease your body's ability to fight infection. Try to avoid being around people who are sick.

Talk to your doctor about your risk of cancer. You may be more at risk for certain types of cancers if you take this medicine.

               
 1  2  3  
               
Advertisement